{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:22:21Z","timestamp":1789726941150,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1124\/jpet.108.143677","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T01:10:45Z","timestamp":1221527445000},"page":"934-940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Effect of Erythromycin on Biological Activities Induced by Clostridium perfringens \u03b1-Toxin"],"prefix":"10.1016","volume":"327","author":[{"given":"Masataka","family":"Oda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Uoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Higashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nagahama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yokochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.108.143677_bib1","doi-asserted-by":"crossref","unstructured":"Aldridge AJ (2002) Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur J Surg 168: 204-214.","DOI":"10.1080\/11024150260102807"},{"key":"10.1124\/jpet.108.143677_bib2","doi-asserted-by":"crossref","unstructured":"Anderson R (1989) Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J Infect Dis 159: 966-973.","DOI":"10.1093\/infdis\/159.5.966"},{"key":"10.1124\/jpet.108.143677_bib3","doi-asserted-by":"crossref","unstructured":"Bryant AE and Stevens DL (1996) Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells. Infect Immun 64: 358-362.","DOI":"10.1128\/iai.64.1.358-362.1996"},{"key":"10.1124\/jpet.108.143677_bib4","doi-asserted-by":"crossref","unstructured":"Bunting M, Lorant DE, Bryant AE, Zimmerman GA, McIntyre TM, Stevens DL, and Prescott SM (1997) Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J Clin Invest 100: 565-574.","DOI":"10.1172\/JCI119566"},{"key":"10.1124\/jpet.108.143677_bib5","unstructured":"Calandra T, Bochud PY, and Heumann D (2002) Cytokines in septic shock. Curr Clin Top Infect Dis 22: 1-23."},{"key":"10.1124\/jpet.108.143677_bib6","doi-asserted-by":"crossref","unstructured":"D\u2019Andrea A, Ma X, Aste-Amezaga M, Paganin C, and Trinchieri G (1995) Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J Exp Med 181: 537-546.","DOI":"10.1084\/jem.181.2.537"},{"key":"10.1124\/jpet.108.143677_bib7","doi-asserted-by":"crossref","unstructured":"Dinarello CA (2004) Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr Opin Pharmacol 4: 378-385.","DOI":"10.1016\/j.coph.2004.03.010"},{"key":"10.1124\/jpet.108.143677_bib8","doi-asserted-by":"crossref","unstructured":"Fujii T, Kadota J, Kawakami K, Iida K, Shirai R, Kaseda M, Kawamoto S, and Kohno S (1995) Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax 50: 1246-1252.","DOI":"10.1136\/thx.50.12.1246"},{"key":"10.1124\/jpet.108.143677_bib9","doi-asserted-by":"crossref","unstructured":"Hand WL, Hand DL, and King-Thompson NL (1990) Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob Agents Chemother 34: 863-870.","DOI":"10.1128\/AAC.34.5.863"},{"key":"10.1124\/jpet.108.143677_bib10","doi-asserted-by":"crossref","unstructured":"Herbertson MJ, Werner HA, Goddard CM, Russell JA, Wheeler A, Coxon R, and Walley KR (1995) Anti-tumor necrosis factor-alpha prevents decreased ventricular contractility in endotoxemic pigs. Am J Respir Crit Care Med 152: 480-488.","DOI":"10.1164\/ajrccm.152.2.7633696"},{"key":"10.1124\/jpet.108.143677_bib11","doi-asserted-by":"crossref","unstructured":"Kadota J, Sakito O, Kohno S, Sawa H, Mukae H, Oda H, Kawakami K, Fukushima K, Hiratani K, and Hara K (1993) A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 147: 153-159.","DOI":"10.1164\/ajrccm\/147.1.153"},{"key":"10.1124\/jpet.108.143677_bib12","doi-asserted-by":"crossref","unstructured":"Kanai K, Asano K, Hisamitsu T, and Suzaki H (2004) Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro. Mediators Inflamm 13: 313-319.","DOI":"10.1080\/09629350400008810"},{"key":"10.1124\/jpet.108.143677_bib13","doi-asserted-by":"crossref","unstructured":"Khan AA, Slifer TR, Araujo FG, and Remington JS (1999) Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int J Antimicrob Agents 11: 121-132.","DOI":"10.1016\/S0924-8579(98)00091-0"},{"key":"10.1124\/jpet.108.143677_bib14","doi-asserted-by":"crossref","unstructured":"Kreidl KO, Green GR, and Wren SM (2002) Intravascular hemolysis from a Clostridium perfringens liver abscess. J Am Coll Surg 194: 387.","DOI":"10.1016\/S1072-7515(01)01169-3"},{"key":"10.1124\/jpet.108.143677_bib15","doi-asserted-by":"crossref","unstructured":"Leirisalo-Repo M (1994) The present knowledge of the inflammatory process and the inflammatory mediators. Pharmacol Toxicol 75 (Suppl 2): 1-3.","DOI":"10.1111\/j.1600-0773.1994.tb01988.x"},{"key":"10.1124\/jpet.108.143677_bib16","doi-asserted-by":"crossref","unstructured":"Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schl\u00f6ndorff J, Tempst P, Choi Y, and Blobel CP (1999) Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 274: 13613-13618.","DOI":"10.1074\/jbc.274.19.13613"},{"key":"10.1124\/jpet.108.143677_bib17","doi-asserted-by":"crossref","unstructured":"Nagahama M, Okagawa Y, Nakayama T, Nishioka E, and Sakurai J (1995) Site-directed mutagenesis of histidine residues in Clostridium perfringens alpha-toxin. J Bacteriol 177: 1179-1185.","DOI":"10.1128\/jb.177.5.1179-1185.1995"},{"key":"10.1124\/jpet.108.143677_bib18","doi-asserted-by":"crossref","unstructured":"Ochi S, Hashimoto K, Nagahama M, and Sakurai J (1996) Phospholipid metabolism induced by Clostridium perfringens alpha-toxin elicits a hot-cold type of hemolysis in rabbit erythrocytes. Infect Immun 64: 3930-3933.","DOI":"10.1128\/iai.64.9.3930-3933.1996"},{"key":"10.1124\/jpet.108.143677_bib19","doi-asserted-by":"crossref","unstructured":"Ochi S, Miyawaki T, Matsuda H, Oda M, Nagahama M, and Sakurai J (2002) Clostridium perfringens alpha-toxin induces rabbit neutrophil adhesion. Microbiology 148: 237-245.","DOI":"10.1099\/00221287-148-1-237"},{"key":"10.1124\/jpet.108.143677_bib20","doi-asserted-by":"crossref","unstructured":"Ochi S, Oda M, Matsuda H, Ikari S, and Sakurai J (2004) Clostridium perfringens alpha-toxin activates the sphingomyelin metabolism system in sheep erythrocytes. J Biol Chem 279: 12181-12189.","DOI":"10.1074\/jbc.M307046200"},{"key":"10.1124\/jpet.108.143677_bib21","doi-asserted-by":"crossref","unstructured":"Oda M, Ikari S, Matsuno T, Morimune Y, Nagahama M, and Sakurai J (2006) Signal transduction mechanism involved in Clostridium perfringens alpha-toxin-induced superoxide anion generation in rabbit neutrophils. Infect Immun 74: 2876-2886.","DOI":"10.1128\/IAI.74.5.2876-2886.2006"},{"key":"10.1124\/jpet.108.143677_bib22","doi-asserted-by":"crossref","unstructured":"Oda M, Matsuno T, Shiihara R, Ochi S, Yamauchi R, Saito Y, Imagawa H, Nagahama M, Nishizawa M, and Sakurai J (2008) The relationship between the metabolism of sphingomyelin species and the hemolysis of sheep erythrocytes induced by Clostridium perfringens alpha-toxin. J Lipid Res 49: 1039-1047.","DOI":"10.1194\/jlr.M700587-JLR200"},{"key":"10.1124\/jpet.108.143677_bib23","doi-asserted-by":"crossref","unstructured":"P\u00e5lsson-McDermott EM and O\u2019Neill LA (2004) Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113: 153-162.","DOI":"10.1111\/j.1365-2567.2004.01976.x"},{"key":"10.1124\/jpet.108.143677_bib24","doi-asserted-by":"crossref","unstructured":"Riedemann NC, Guo RF, and Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9: 517-524.","DOI":"10.1038\/nm0503-517"},{"key":"10.1124\/jpet.108.143677_bib25","unstructured":"Rubin BK and Tamaoki J (2000) Macrolide antibiotics as biological response modifiers. Curr Opin Investig Drugs 1: 169-172."},{"key":"10.1124\/jpet.108.143677_bib26","doi-asserted-by":"crossref","unstructured":"Sakurai J, Ochi S, and Tanaka H (1994) Regulation of Clostridium perfringens alpha-toxin-activated phospholipase C in rabbit erythrocyte membranes. Infect Immun 62: 717-721.","DOI":"10.1128\/iai.62.2.717-721.1994"},{"key":"10.1124\/jpet.108.143677_bib27","doi-asserted-by":"crossref","unstructured":"Sakurai J, Nagahama M, and Oda M (2004) Clostridium perfringens alpha-toxin: characterization and mode of action. J Biochem 136: 569-574.","DOI":"10.1093\/jb\/mvh161"},{"key":"10.1124\/jpet.108.143677_bib28","doi-asserted-by":"crossref","unstructured":"Sato K, Suga M, Akaike T, Fujii S, Muranaka H, Doi T, Maeda H, and Ando M (1998) Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. Am J Respir Crit Care Med 157: 853-857.","DOI":"10.1164\/ajrccm.157.3.9703098"},{"key":"10.1124\/jpet.108.143677_bib29","doi-asserted-by":"crossref","unstructured":"Schmid EE (1971) The macrolide group of antibiotics: mode of action. Antibiot Chemother 17: 52-66.","DOI":"10.1159\/000392363"},{"key":"10.1124\/jpet.108.143677_bib30","doi-asserted-by":"crossref","unstructured":"Simpson JL, Powell H, Boyle MJ, Scott RJ, and Gibson PG (2008) Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 177: 148-155.","DOI":"10.1164\/rccm.200707-1134OC"},{"key":"10.1124\/jpet.108.143677_bib31","doi-asserted-by":"crossref","unstructured":"Stevens DL (2000) The pathogenesis of clostridial myonecrosis. Int J Med Microbiol 290: 497-502.","DOI":"10.1016\/S1438-4221(00)80074-0"},{"key":"10.1124\/jpet.108.143677_bib32","doi-asserted-by":"crossref","unstructured":"Stevens DL and Bryant AE (1997) Pathogenesis of Clostridium perfringens infection: mechanisms and mediators of shock. Clin Infect Dis 25: S160-S164.","DOI":"10.1086\/516249"},{"key":"10.1124\/jpet.108.143677_bib33","doi-asserted-by":"crossref","unstructured":"Sugahara T and Osaka A (1970) Two molecular forms of Clostridium perfringens alpha-toxin associated with lethal, hemolytic and enzymatic activities. Jpn J Med Sci Biol 23: 61-66.","DOI":"10.7883\/yoken1952.23.61"},{"key":"10.1124\/jpet.108.143677_bib34","doi-asserted-by":"crossref","unstructured":"Titball RW (1997) Bacterial phospholipases. Trends Microbiol 5: 265.","DOI":"10.1016\/S0966-842X(97)88834-8"},{"key":"10.1124\/jpet.108.143677_bib35","doi-asserted-by":"crossref","unstructured":"Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, and Cerami A (1987) Anti-cachectin\/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664.","DOI":"10.1038\/330662a0"},{"key":"10.1124\/jpet.108.143677_bib36","doi-asserted-by":"crossref","unstructured":"Tsai WC, Rodriguez ML, Young KS, Deng JC, Thannickal VJ, Tateda K, Hershenson MB, and Standiford TJ (2004) Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. Am J Respir Crit Care Med 170: 1331-1339.","DOI":"10.1164\/rccm.200402-200OC"},{"key":"10.1124\/jpet.108.143677_bib37","doi-asserted-by":"crossref","unstructured":"Tzianabos AO, Russell PR, Onderdonk AB, Gibson FC 3rd, Cywes C, Chan M, Finberg RW, and Kasper DL (1999) IL-2 mediates protection against abscess formation in an experimental model of sepsis. J Immunol 163: 893-897.","DOI":"10.4049\/jimmunol.163.2.893"},{"key":"10.1124\/jpet.108.143677_bib38","doi-asserted-by":"crossref","unstructured":"van Setten PA, Monnens LA, Verstraten RG, van den Heuvel LP, and van Hinsbergh VW (1996) Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 88: 174-183.","DOI":"10.1182\/blood.V88.1.174.174"},{"key":"10.1124\/jpet.108.143677_bib39","doi-asserted-by":"crossref","unstructured":"Yoshimura A, Hara Y, Kaneko T, and Kato I (1997) Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. J Periodontal Res 32: 279-286.","DOI":"10.1111\/j.1600-0765.1997.tb00535.x"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524347202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524347202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.108.143677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:48:20Z","timestamp":1740005300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524347202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0022356524347202"],"URL":"https:\/\/doi.org\/10.1124\/jpet.108.143677","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Erythromycin on Biological Activities Induced by Clostridium perfringens \u03b1-Toxin","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.108.143677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}